Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 3Phase 2/3 2Phase NA 1Phase 1/2 1Phase 1 1

Status

Completed 47Recruiting 27Unknown 20Terminated 15Active not recruiting 12Withdrawn 5Not yet recruiting 5Suspended 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Carcinoma, Hepatocellular 4Disease Progression 1Cirrhosis, Familial, with Pulmonary Hypertension 1Cholangiocarcinoma 1

Interventions

Carboplatin 79Cisplatin 74Bevacizumab 62Radiotherapy 59Drug Therapy 57Capecitabine 57Oxaliplatin 56tislelizumab 54toripalimab 45Paclitaxel 44Gemcitabine 43pembrolizumab 40anlotinib 40Specimen Handling 39sintilimab 37Cyclophosphamide 34130-nm albumin-bound paclitaxel 34Injections 30Pemetrexed 28camrelizumab 26Surgical Procedures, Operative 26Magnetic Resonance Spectroscopy 25lenvatinib 24apatinib 23Docetaxel 23Etoposide 22S 1 (combination) 21Fluorouracil 21Immune Checkpoint Inhibitors 20Biopsy 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Not yet recruiting × regorafenib × Clear all
NCT07495579 2026-05-27

REVIVE

Asan Medical Center

Phase 2 Not yet recruiting
146 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT07514429 2026-04-07

RELEVANT-HCC

Asan Medical Center

Phase 2 Not yet recruiting
24 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT07514455 2026-04-07

RECOMEND

Asan Medical Center

Phase 2 Not yet recruiting
20 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Disease Progression

NCT07078305 2025-07-22

Comparing the Combination of Trastuzumab and Regorafenib With Regorafenib Monotherapy for Advanced Hepatocellular Carcinoma After First-line Treatment

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Not yet recruiting
134 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT06946849 2025-04-27

SED-RO-ICC

Shanghai Zhongshan Hospital

Phase 2 Not yet recruiting
76 enrolled
Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡